✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Jenburkt Pharmaceuticals Ltd.

JENBURPH

Market Cap
₹519 Cr.
P/E
14.95

Jenburkt Pharmaceuticals Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
519 Cr
PE
PE
14.95
Prom Holding
Prom Holding
46.64 %
ROE (%)
ROE (%)
18.66
ROCE (%)
ROCE (%)
25.23
Div Yield (%)
Div Yield (%)
-
Sales
Sales
168 Cr
OPM (%)
OPM (%)
25.92 %
Debt to Equity
Debt to Equity
0.01
Institutions
Institutions
0.12 %
Individual < 2 lac
Individual < 2 lac
31.34 %
No. of Shareholders
No. of Shareholders
6,999
View more
Edit Ratio's

About

Jenburkt Pharmaceuticals Limited is an India-based company specializing in pharmaceutical form… Read more
Low
944
52W Range
High
1410
  • Jenburkt Pharma
  • Kilitch Drugs(India)
  • Prevest Denpro

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Jenburkt Pharmaceuticals Ltd. Business

    Jenburkt Pharmaceuticals Limited, based in India, specializes in manufacturing and marketing pharmaceutical formulations and healthcare products under two divisions: consumer and pharmaceutical. They have a diverse product portfolio with approximately 50 brands promoted through doctors.

    Jenburkt Pharma major competitors are Prevest Denpro, Kilitch Drugs(India), Albert David, Zim Laboratories, Shivalik Rasayan, Medicamen Biotech, Medico Remedies.
    Market Cap of Jenburkt Pharma is ₹515 Crs.
    While the median market cap of its peers are ₹457 Crs.

    Jenburkt Pharma seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Jenburkt Pharmaceuticals Ltd.
    View the discussion on ValuePickr
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material